CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, Minjin Lee, Sehwa Kim, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
J Liver Cancer. 2019;19(2):117-127.   Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.117

Excel Download

An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
Journal of Liver Cancer. 2019;19(2):117-127   Crossref logo
Link1 Link2 Link3

Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib—A cost-effectiveness analysis
PLOS ONE. 2018;13(11):e0207132   Crossref logo
Link1

Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment
Oncology. 2018;95(2):91-99   Crossref logo
Link1 Link2

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
Clinical and Molecular Hepatology. 2020;26(3):328-339   Crossref logo
Link1 Link2 Link3

Complete Response Associated With Combination Treatment Regorafenib and Sintilimab in a Sorafenib-refractory Hepatocellular Carcinoma Patient
. 2020;   Crossref logo
Link1 Link2

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
Hepatology. 2015;62(3):784-791   Crossref logo
Link1 Link2

Su1476 Sorafenib Associated Survival in Treatment Naïve Versus Treatment Experienced Patients With Advanced Hepatocellular Carcinoma
Gastroenterology. 2016;150(4):S516   Crossref logo
Link1 Link2

Patterns of Presentation, Referral, and Treatment of Hepatocellular Carcinoma in a Pre-Sorafenib Era: Experience of a Canadian Provincial Cancer Agency
Current Oncology. 2011;18(6):297-303   Crossref logo
Link1

Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy
Hepatology Research. 2018;48(12):956-966   Crossref logo
Link1 Link2

Sorafenib in the treatment of Hepatocellular carcinoma (HCC) patients with microvascular infiltration: a systematic review and meta-analysis
. 2020;   Crossref logo
Link1 Link2